Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amir, N.
Right arrow Articles by Christensen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amir, N.
Right arrow Articles by Christensen, E.
NEUROLOGY 1987;37:1654
© 1987 American Academy of Neurology

Glutaric aciduria type I

Clinical heterogeneity and neuroradiologic features

Naomi Amir, MD, Orly El-Peleg, MD, Ruth S. Shalev, MD and Ernst Christensen, PhD

From the Florence Miller Neuropediatric Diagnostic Unit (Drs. Amir and Shalev), and the Department of Pediatrics (Dr. El-Peleg), Bikur Cholim Hospital, Jerusalem, Israel; and the Section of Clinical Genetics (Dr. Christensen), Metabolic Laboratory, Rigshospitalet, Copenhagen, Denmark.

We present four patients, two pairs of siblings, with glutaric aciduria type I (GA I). All four had undetectable glutaryl-CoA dehydrogenase activity on fibroblast culture and massive urinary excretion of glutaric acid. All had serum carnitine deficiency at time of diagnosis except one patient who was diagnosed neonatally. All had a unique pattern of frontotemporal atrophy on CT. Remarkably, in both sibling pairs, one child was asymptomatic. This suggests that the biochemical markers hitherto identified with GA I do not encompass the entire scope of the metabolic or enzymatic abnormalities. Alternatively, as yet unidentified mechanisms might spare or delay the destructive process.

Address correspondence and reprint requests to Dr. Amir, Bikur Cholim Hospital, 5 Straws Street, Jerusalem, Israel.

Received October 8, 1986. Accepted for publication in final form January 15, 1987.




This article has been cited by other articles:


Home page
J Child NeurolHome page
N. S. Baker, H. B. Sarnat, R. M. Jack, K. Patterson, D. W. Shaw, and S. P. Herndon
D-2-Hydroxyglutaric Aciduria: Hypotonia, Cortical Blindness, Seizures, Cardiomyopathy, and Cylindrical Spirals in Skeletal Muscle
J Child Neurol, January 1, 1997; 12(1): 31 - 36.
[Abstract] [PDF]


Home page
J Child NeurolHome page
Y. Awaad, H. Shamato, and H. Chugani
Hemidystonia Improved by Baclofen and PET Scan Findings in a Patient With Glutaric Aciduria Type I
J Child Neurol, March 1, 1996; 11(2): 167 - 169.
[PDF]


Home page
J Child NeurolHome page
P. T. Ozand and G. G. Gascon
Topical Review Article: Organic Acidurias: A Review. Part 1
J Child Neurol, July 1, 1991; 6(3): 196 - 219.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.